Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 971 Records) |
Query Trace: FLT3[original query] |
---|
Acute myeloid leukemia with concurrent NPM1 and RUNX1 mutations. Leukemia research reports 2023 9 20 100385. Zhuang Zuo, L Jeffrey Medeiros, C Cameron Y |
Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia-Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022. Cancers 2023 9 15 (18): . Ma?gorzata Czoga?a, Wojciech Czoga?a, Katarzyna Pawi?ska-W?sikowska, Teofila Ksi??ek, Karolina Bukowska-Strakova, Barbara Sikorska-Fic, Pawe? ?aguna, Anna Fa?kowska, Katarzyna Drabko, Katarzyna Muszy?ska-Ros?an, Maryna Krawczuk-Rybak, Marta Koz?owska, Ninela Irga-Jaworska, Karolina Zielezi?ska, Tomasz Urasi?ski, Natalia Bartoszewicz, Jan Styczy?ski, Jolanta Skalska-Sadowska, Jacek Wachowiak, Anna Rodziewicz-Konarska, Krzysztof Ka?wak, Ma?gorzata Ciebiera, Rados?aw Chaber, Agnieszka Mizia-Malarz, Agnieszka Choda?a-Grzywacz, Gra?yna Karolczyk, Katarzyna Bobeff, Wojciech M?ynarski, Katarzyna Mycko, Wanda Badowska, Renata Tomaszewska, Tomasz Szczepa?ski, Katarzyna Machnik, Natalia Zamorska, Walentyna Balwierz, Szymon Skocz |
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers 2023 9 15 (18): . Jan Korbecki, Patrycja Kupnicka, Katarzyna Barczak, Mateusz Bosiacki, Pawe? Zi?tek, Dariusz Chlubek, Irena Baranowska-Bosiac |
[Characteristics of genetic variants in 134 patients with Acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 9 40 (10): 1222-1227. Miao He, Xiaochen Zhao, Hongjuan Tian, Shuting Zhang, Fangqing Zhao, Xi Zhang, Tao |
Morphological, cytogenetic and molecular characterisation of FLT3 mutations in Pakistani patients with de novo acute myeloid leukaemia: A single centre experience. The Malaysian journal of pathology 2023 9 45 (2): 205-214. M Faiz, F Rash |
Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients. Molecular biology reports 2023 8 . Ayad M Ali, Gaza F Sal |
Prognostic impact of FLT3-ITD mutation on NPM1 acute myeloid leukaemia patients and related molecular mechanisms. British journal of haematology 2023 8 . Xin'an Pan, Yingjun Chang, Guorui Ruan, Fangfang Wei, Hao Jiang, Qian Jiang, Xiaojun Huang, Xiaosu Zh |
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia 2023 8 . Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail J Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn, Claudia Walter, Karlheinz Holzmann, Yong Hao, Sue Naim, Nicholas Schreck, Julia Krzykalla, Axel Benner, Harold N Keer, Mohammad Azab, Konstanze Döhner, Hartmut Döhn |
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
Outcomes of Patients with FLT3 Positive Acute Myeloid Leukaemia; an Experience from a Tertiary Care Hospital in Karachi, Pakistan. Journal of cancer & allied specialties 2023 8 9 (2): 553. Maria Zulfiqar, Natasha Ali, Usman Shaikh, Hamzah Jehanzeb, Salman Arif, Zurrya Fasih Khan, Nabiha Saeed, Zeeshan Ans |
The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. PloS one 2023 7 18 (7): e0289014. Sohaib M Al-Khatib, Obada Ababneh, Hassann Abushukair, Nour Abdo, Laith N Al-Eit |
Distinct karyotypic and mutational landscape in trisomy AML. British journal of haematology 2023 12 . Stephen S Y Lam, Sze P Tsui, C Y Fung, Nicole Y Saw, Asif Javed, Alvin H W Ip, Edmond S K Ma, Anskar Y H Leu |
[Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 12 44 (10): 845-850. L L Wang, S N Ch |
Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia. Asian Pacific journal of cancer prevention : APJCP 2023 12 24 (12): 4301-4307. Omnia Kaheled, Salah Aref, Nadia El Menshawy, Mohamed Aref, Mohamed Ay |
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 2023 12 30 (12): 10410-10436. Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Sch |
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology 2023 12 . Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Antoine N Saliba, Mehrdad Hefazi Torghabeh, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Teffe |
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients. European journal of haematology 2023 11 . C Petit, C Saillard, B Mohty, Y Hicheri, F Villetard, V Maisano, A Charbonnier, J Rey, E D'Incan, C Rouzaud, V Gelsi-Boyer, A Murati, A C Lhoumeau, A Ittel, M J Mozziconacci, A S Alary, M-A Hospital, N Vey, S Garci |
Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations. Open medicine (Warsaw, Poland) 2023 11 18 (1): 20230830. Li Sheng, Yajiao Liu, Yingying Zhu, Jingfen Zhou, Haiying H |
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation. Pharmacogenomics and personalized medicine 2023 11 16 1011-1026. Rui Huang, Yi-Ting Zhang, Yu Lin, Ru-Li Pang, Zhi Yang, Wei-Hua Zh |
Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience. Clinical laboratory 2023 11 69 (11): . Eunhee Han, Soorack Ryu, Dohyang Kim, Eun-Ha Koh, Jung-Hyun Byun, Dong-Hyun L |
Rare variant associations with plasma protein levels in the UK Biobank. Nature 2023 10 622 (7982): 339-347. Ryan S Dhindsa, Oliver S Burren, Benjamin B Sun, Bram P Prins, Dorota Matelska, Eleanor Wheeler, Jonathan Mitchell, Erin Oerton, Ventzislava A Hristova, Katherine R Smith, Keren Carss, Sebastian Wasilewski, Andrew R Harper, Dirk S Paul, Margarete A Fabre, Heiko Runz, Coralie Viollet, Benjamin Challis, Adam Platt, , Dimitrios Vitsios, Euan A Ashley, Christopher D Whelan, Menelas N Pangalos, Quanli Wang, Slavé Petrovs |
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. Molecular diagnosis & therapy 2024 4 . Youngeun Lee, Soo Hyun Seo, Jinho Kim, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Kyoung Un Park, Sang Mee Hwa |
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. Leukemia research 2024 4 140 107497. Alberto Risueño, Wendy L See, Iryna Bluemmert, Stéphane de Botton, Courtney D DiNardo, Amir T Fathi, Andre C Schuh, Pau Montesinos, Paresh Vyas, Thomas Prebet, Anita Gandhi, Maroof Has |
FLAG/FLAG-Ida Regimen in Secondary and Relapsed/Refractory Acute Myeloid Leukemia-Even in the Era of New Treatment Modalities Still a Significant Player. Journal of clinical medicine 2024 4 13 (7): . Saša Anžej Doma, Matjaž Sever, Gorazd Jakoš, Helena Podgorn |
Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India. Journal of hematopathology 2024 1 16 (1): 17-25. Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Sin |
Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata. Frontiers in endocrinology 2024 1 14 1309620. Xue-Yong Zheng, Yan-Ping Ma, Bo Zhang, Yan-Xin Chen, Lei Tang, Xiao-Hua Tai, Jia-Hao C |
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. American journal of hematology 2024 1 . Nour Moukalled, Myriam Labopin, Jurjen Versluis, Gérard Socié, Didier Blaise, Urpu Salmenniemi, Alessandro Rambaldi, Tobias Gedde-Dahl, Eleni Tholouli, Nicolaus Kröger, Jean-Henri Bourhis, Peter Von Dem Borne, Etienne Daguindau, Edouard Forcade, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Ali Bazarbachi, Mohamad Moh |
Prognostic impact of CEBPA mutational subgroups in adult AML. Leukemia 2024 1 . Julia-Annabell Georgi, Sebastian Stasik, Michael Kramer, Manja Meggendorfer, Christoph Röllig, Torsten Haferlach, Peter Valk, David Linch, Tobias Herold, Nicolas Duployez, Franziska Taube, Jan Moritz Middeke, Uwe Platzbecker, Hubert Serve, Claudia D Baldus, Carsten Muller-Tidow, Claudia Haferlach, Sarah Koch, Wolfgang E Berdel, Bernhard J Woermann, Utz Krug, Jan Braess, Wolfgang Hiddemann, Karsten Spiekermann, Emma L Boertjes, Robert K Hills, Alan Burnett, Gerhard Ehninger, Klaus Metzeler, Maja Rothenberg-Thurley, Annika Dufour, Hervé Dombret, Cecile Pautas, Claude Preudhomme, Laurene Fenwarth, Martin Bornhäuser, Rosemary Gale, Christian Thie |
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 1 JCO2300943. Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dillon, Steven Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: